LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

Search

Organon & Co

Suletud

SektorTervishoid

9.87 -1.2

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

9.72

Max

10.13

Põhinäitajad

By Trading Economics

Sissetulek

-22M

87M

Müük

-79M

1.5B

P/E

Sektori keskmine

3.403

50.291

Aktsiakasum

1.02

Dividenditootlus

0.82

Kasumimarginaal

5.75

Töötajad

10,000

EBITDA

-13M

325M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+40% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.82%

2.40%

Järgmine tulemuste avaldamine

5. aug 2025

Järgmine dividendimakse kuupäev

11. sept 2025

Järgmine aktsia dividendi kuupäev (ex-date)

15. aug 2025

Turustatistika

By TradingEconomics

Turukapital

-1.6B

2.5B

Eelmine avamishind

11.07

Eelmine sulgemishind

9.87

Uudiste sentiment

By Acuity

38%

62%

117 / 380 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Organon & Co Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. juuni 2025, 20:51 UTC

Tulu

These Stocks Moved the Most Today: Nike, Nvidia, Coinbase, Palantir, Boeing, Newmont, Core Scientific, and More -- Barrons.com

27. juuni 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27. juuni 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

27. juuni 2025, 20:48 UTC

Market Talk

Computer Lobby Cheers Move to Punish Canada Over Digital Tax -- Market Talk

27. juuni 2025, 20:46 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

27. juuni 2025, 20:46 UTC

Market Talk

Canada Dismissal of Risk From Digital Tax Is 'Shocking' -- Market Talk

27. juuni 2025, 19:31 UTC

Market Talk

Canada CEOs Call for Carney to Drop Digital Tax -- Market Talk

27. juuni 2025, 19:19 UTC

Market Talk

Oil Posts Weekly Loss As Geopolitical Premium Evaporates -- Market Talk

27. juuni 2025, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

27. juuni 2025, 18:57 UTC

Omandamised, ülevõtmised, äriostud

Russian Oligarch Roman Abramovich Is Evraz PLC's Largest Shareholder With 29% Stake -- WSJ

27. juuni 2025, 18:57 UTC

Omandamised, ülevõtmised, äriostud

Evraz North America Parent Evraz PLC Remains Under Sanction by U.K. -- WSJ

27. juuni 2025, 18:57 UTC

Omandamised, ülevõtmised, äriostud

Evraz North America Employs About 3,400 People, Has 3.5 Million Tons of Finished Steel Capacity -- WSJ

27. juuni 2025, 18:57 UTC

Omandamised, ülevõtmised, äriostud

Atlas Holdings to Buy Evraz North America for Up to $500 Million, Companies Say -- WSJ

27. juuni 2025, 18:57 UTC

Omandamised, ülevõtmised, äriostud

Atlas Holdings to Buy Evraz North America for Up to $500 Million, Companies Say -- WSJ

27. juuni 2025, 18:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. juuni 2025, 18:42 UTC

Market Talk

Canada's Carney 'Likely Amenable' to Dropping Digital-Services Tax -- Market Talk

27. juuni 2025, 18:39 UTC

Market Talk
Tulu

Nike's Second-Half Prospects Can Get Better as Worst is Behind it -- Market Talk

27. juuni 2025, 18:29 UTC

Market Talk

Canada Recession Risks Likely to Rise With Trump's Termination of Tariff Talks -- Market Talk

27. juuni 2025, 18:18 UTC

Market Talk

Canadian Dollar Sharply Weakens on Trump's Surprise End to US-Canada Tariff Talks -- Market Talk

27. juuni 2025, 18:16 UTC

Market Talk

Trump's Threat Against Canada Weighs Down Treasurys -- Market Talk

27. juuni 2025, 17:16 UTC

Market Talk

U.S. Oil Rig Count Falls by 6 to 432 -- Market Talk

27. juuni 2025, 17:08 UTC

Tulu

McDonald's Stock Has Slipped. One Analyst Sees 21% Upside. -- Barrons.com

27. juuni 2025, 16:52 UTC

Omandamised, ülevõtmised, äriostud

Nike Stock Soars After Earnings. Is It Time to Just Buy It? -- Barrons.com

27. juuni 2025, 16:22 UTC

Tulu

These Stocks Are Moving the Most Today: Nike, Nvidia, Coinbase, Palantir, Boeing, Newmont, Core Scientific, and More -- Barrons.com

27. juuni 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

27. juuni 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27. juuni 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

27. juuni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

27. juuni 2025, 15:59 UTC

Market Talk

Gold Futures Slump on Improving Risk Appetite -- Market Talk

27. juuni 2025, 15:56 UTC

Market Talk

Nvidia Again Helping To Power New S&P Highs -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Organon & Co Prognoos

Hinnasiht

By TipRanks

40% tõus

12 kuu keskmine prognoos

Keskmine 14 USD  40%

Kõrge 18 USD

Madal 10 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Organon & Co 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

7 ratings

2

Osta

3

Hoia

2

Müü

Tehniline skoor

By Trading Central

8.53 / 9.18Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

No Evidence

Sentiment

By Acuity

117 / 380 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Organon & Co

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.